Nasopharyngeal carcinoma presenting as proptosis in a child: a diagnostic dilemma
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20150905Keywords:
Pediatric, Nasopharyngeal carcinoma, Rare, Proptosis, DilemmaAbstract
Nasopharyngeal carcinoma (NPC), although rare but does occur in pediatric age group and can present with variable non-specific signs and symptoms. The objective of this report is to emphasize that, because of its rarity, it is not clinically suspected and kept in differential diagnosis of nasopharyngeal mass in children, leading to delayed diagnosis and significant therapeutic implications. We hereby, describe a case of 10 year old boy who presented with bilateral cervical lymphadenopathy and simultaneously developing proptosis of the left eye, which is one of the important rare manifestation of NPC, that creates a diagnostic challenge.
References
Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O’Leary M, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28:2625-34.
Dickson PV, Davidoff AM. Malignant neoplasms of the head and neck. Semin Pediatr Surg. 2006;15:92-8.
Polychronopoulou S, Kostaridou S, Panagiotou JP, Stefanaki K, Papadakis V, Florentin L, et al. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years. Pediatr Hematol Oncol. 2004;21:393-402.
Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol. 2002;13:1007-15.
Kataki AC, Simons MJ, Das AK, Sharma K, Mehra NK. Nasopharyngeal carcinoma in the Northeastern states of India. Chin J Cancer. 2011;30:106-13.
Cengiz K, Kumral TL, Yıldırım G. Diagnosis of pediatric nasopharynx carcinoma after recurrent adenoidectomy. Case Rep Otolaryngol. 2013;2013:653963.
Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda: National Cancer Institute, National Institutes of Health; 1999.
Sultan I, Casanova M, Ferrari A, Rihani R, Rodriguez-Galindo C. Differential features of nasopharyngeal carcinoma in children and adults: a SEER study. Pediatr Blood Cancer. 2010;55:279-84.
Guruprasad B, Tanvir P, Rohan B, Kavitha S, Naik SM, Appaji L. Paediatric nasopharyngeal carcinoma: an 8-year study from a tertiary care cancer centre in South India. Indian J Otolaryngol Head Neck Surg. 2013;65:131-4.
Brennan B. Nasopharyngeal carcinoma. Orphanet J Rare Dis. 2006;1:23.
Otulana TO, Sogebi OA, Onabolu OO, Ajibode HA, Bodunde OT. Nasopharyngeal malignancy presenting as proptosis in children. Nig Med J. 2011;52:133-7.
Hsu W, Wang AG. Nasopharyngeal carcinoma with orbital invasion. Eye. 2004;18:833-8.
Luo CB, Teng MMH, Chen SS, Liring JF, Guo WY, Chang T. Orbital invasion in nasopharyngeal carcinoma: evaluation with computed tomography and magnetic resonance imaging. Chin Med J. 1998;61:382-8.
Sahraoui S, Acharki A, Benider A, Bouras N, Kahlain A. Nasopharyngeal carcinoma in children under 15 years of age: a retrospective review of 65 patients. Ann Oncol. 1999;10:1499-502.
Louis CU, Paulino AC, Gottschalk S, Bertuch AA, Chintagumpala M, Heslop HE, et al. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol. 2007;29:500-5.
Straathof KC, Bollard CM, Popat U, Huls MH, Lopez T, Morriss MC, et al. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes. Blood. 2005;105:1898-904.